Owner Pfizer Products Inc.

Inventors Raillard, Sun Ai; Kim, Seran; Krebber, Anke; Chen, Yan; Stutzman-Engwall Kim Jonelle; Minshull, Jeremy Stephen; Gustafsson, Claes Eric Daniel

Agent Shelston IP

Pub. Number AU-B-2003245052

PCT Number PCT/IB03/00348

PCT Pub. Number WO2003/068955

Priority 60/356,222 12.02.02 US

Filing date 31 January 2003

Wipo publication date 4 September 2003

Acceptance publication date 31 July 2008

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7048 (2006.01)

A61P 33/00 (2006.01) Antiparasitic agents

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12N 15/60 (2006.01) Mutation or genetic engineering - Lyases (4)

C12P 17/18 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

C12P 19/62 (2006.01) Preparation of compounds containing saccharide radicals

C12R 1/465 (2006.01)